Serum Institute invests $68m in Oxford Biomedica to expand vector capacity
Oxford Biomedica will add 39,000 square feet of advanced manufacturing space at its Oxbox site in the UK following an investment from the Serum Institute of India. The £50 million ($68 million) investment from Indian vaccine giant Serum Institute of India will be used to develop the fallow area ...
Lonza says its presence in China is growing despite a short-term talent shortage in the industry.
“The Chinese pharma market is big and grow ...
The US FDA has approved a fourth product for Seagen and the twelfth ADC therapeutic in the form of cervical cancer drug Tivdak.
First up, it ...
Gilead Sciences says the advent of cell therapies into second line treatments and increased competition in the space will help boost the “under ...
Moderna’s mRNA technology platform will be combined with AbCellera’s AI-powered antibody discovery platform to develop mRNA-encoded antibody ...
Recent Tweets
-
RT @IndependentSol4: In the latest episode of the @BioProInsider Expression Platform podcast, @GSK relates its experience of adopting a… https://t.co/ZlBo8mWRJL
1 month ago
-
RT @BioProcessIntl: Editor @Dan5tanton speaks with Sam Machour from Samsung Biologics about the rapid response by both his company and… https://t.co/tAH5P3kAeb
3 months ago
-
RT @Dan5tanton: In the latest example of pandemic-related collaboration, @Novartis is prepping to make the drug substance for Roche… https://t.co/IpIbSP7F1c
5 months ago
-
RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd
6 months ago
Trending
Downstream Processing
The Effect of Benzonase Endonuclease Addition to Purification of Sabin Poliovirus Type 3
Analytical
eBook: Product Variants in Bioprocesses
Biosimilars
Biosimilar Structural Comparison of Commercially Sourced Reference Standards by MMS Rapidly Detects Subtle but Critical Differences to Correctly Predict Activity for Use in an ELISA Product
Cell Culture Media
Enabling High-Performing
Perfusion Cell Culture